Current Status, Opportunities, and Challenges of Exosomes in Oral Cancer Diagnosis and Treatment

Hongyu Liu,Yisheng Huang,Mingshu Huang,Zhijie Huang,Qin Wang,Ling Qing,Li Li,Shuaimei Xu,Bo Jia

DOI: https://doi.org/10.2147/IJN.S365594

IF: 7.033

2022-06-16

International Journal of Nanomedicine

Abstract:Hongyu Liu, 1 Yisheng Huang, 1 Mingshu Huang, 1 Zhijie Huang, 1 Qin Wang, 1 Ling Qing, 1 Li Li, 1 Shuaimei Xu, 2 Bo Jia 1 1 Department of Oral Surgery, Stomatological Hospital, Southern Medical University, Guangzhou, People's Republic of China; 2 Department of Endodontics, Stomatological Hospital, Southern Medical University, Guangzhou, People's Republic of China Correspondence: Shuaimei Xu; Bo Jia, Email ; Oral cancer is one of the most common cancers in the world, with more than 300,000 cases diagnosed each year, of which oral squamous cell carcinoma accounts for more than 90%, with a 5-year survival rate of only 40– 60%, and poor prognosis. Exploring new strategies for the early diagnosis and treatment of oral cancer is key to improving the survival rate. Exosomes are nanoscale lipid bilayer membrane vesicles that are secreted by almost all cell types. During the development of oral cancer, exosomes can transport their contents (DNA, RNA, proteins, etc) to target cells and promote or inhibit the proliferation, invasion, and metastasis of oral cancer cells by influencing the host immune response, drug-resistant metastasis, and tumour angiogenesis. Therefore, exosomes have great potential and advantages as biomarkers for oral cancer diagnosis, and as drug delivery vehicles or targets for oral cancer therapy. In this review, we first describe the biogenesis, biological functions, and isolation methods of exosomes, followed by their relationship with oral cancer. Here, we focused on the potential of exosomes as oral cancer biomarkers, drug carriers, and therapeutic targets. Finally, we provide an insightful discussion of the opportunities and challenges of exosome application in oral cancer diagnosis and treatment, intending to offer new ideas for the clinical management of oral cancer. Keywords: exosomes, oral cancer, biomarkers, drug delivery vehicles, therapeutic target As the first part of the upper gastrointestinal tract, the oral cavity is responsible for food intake, mastication, articulation, swallowing, sensation and expression. 1 The normal performance of these physiological functions is inevitably affected to a greater or lesser extent by oral cancer, and the quality of life of most clinical patients is severely reduced in the late stage due to postoperative cosmetic defects and loss of oral and maxillofacial functions. 2 Oral cancer, according to the International Classification of Diseases, Tenth Revision [ICD-10], includes cancers of the lip, cheek, tongue, gingiva, floor of the mouth, hard palate, and other unspecified parts of the oral cavity. 3 Oral squamous cell carcinoma (OSCC) accounts for more than 90% of these cancers 4–6 and is the most common malignancy of the head and neck. It has a high prevalence worldwide and is a major public health concern. In 2020, the number of new cases of OSCC worldwide was approximately 377,000, and the number of deaths in the same year was approximately 177,000. 7 Early detection, even at the preclinical stage, is essential to reduce the morbidity and mortality of OSCC. Some studies have shown that patients with oral cancer can have a 5-year survival rate of more than 80% if diagnosed early (stages I and II). Unfortunately, up to 50% of oral cancers are diagnosed at an advanced stage (stages III and IV) after the onset of symptoms, such as pain, bleeding, or oral and maxillofacial masses. The risk of developing advanced oral cancer is significantly higher when the diagnosis is delayed for more than one month, and treatment for patients with advanced oral cancer is not only costly but also has a poor prognosis. 8,9 Therefore, the early diagnosis of oral cancer is closely related to the prognosis, and it is urgent to develop methods for the early diagnosis thereof. OSCC has a high potential for local infiltration and lymph node metastasis, 4–6 and once metastasis is present, conventional treatment approaches fail to achieve satisfactory results. Despite the development of multidisciplinary and comprehensive sequential treatment strategies and levels for OSCC, the 5-year survival rate has not improved significantly in the past decades (remaining around 50%). 10–13 Therefore, in addition to focusing on early diagnosis of oral cancer, finding emerging strategies for targeted treatment is an effective way to reduce mortality and improve patients' quality of life. The discovery of early diagnostic markers and targets for oral cancer treatment is the focus of current research. 14 Extracellular vesicles are small membrane-derived vesicles secreted into the extracellular space. Based on the size of extracellular vesicles, they are classified into three main typ -Abstract Truncated-

pharmacology & pharmacy,nanoscience & nanotechnology